本页面由Tiger Trade Technology Pte. Ltd.提供服务

4D Molecular Therapeutics

8.57
-0.7600-8.15%
成交量:117.60万
成交额:1,042.63万
市值:4.37亿
市盈率:-3.54
高:9.72
开:9.19
低:8.45
收:9.33
52周最高:12.34
52周最低:2.24
股本:5,100.79万
流通股本:3,678.36万
量比:1.04
换手率:3.20%
股息:- -
股息率:- -
每股收益(TTM):-2.4186
每股收益(LYR):-2.4200
净资产收益率:-27.57%
总资产收益率:-17.34%
市净率:0.86
市盈率(LYR):-3.54

数据加载中...

2025/07/02

重要事件披露

Form 8-K - Current report
2025/06/20

重要事件披露

Form 8-K - Current report
2025/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/08

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/05/08

重要事件披露

Form 8-K - Current report
2025/02/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/28

重要事件披露

Form 8-K - Current report
2025/02/10

重要事件披露

Form 8-K - Current report
2025/01/10

重要事件披露

Form 8-K - Current report
2024/12/11

重要事件披露

Form 8-K - Current report
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/13

重要事件披露

Form 8-K - Current report
2024/11/13

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/09/18

重要事件披露

Form 8-K - Current report
2024/08/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]